- Home
- BCYC vs CLOV Comparison
BCYC vs CLOV Comparison
Compare BCYC & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- CLOV
- Stock Information
- Founded
- BCYC 2009
- CLOV 2014
- Country
- BCYC United Kingdom
- CLOV United States
- Employees
- BCYC N/A
- CLOV N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- CLOV Medical Specialities
- Sector
- BCYC Health Care
- CLOV Health Care
- Exchange
- BCYC Nasdaq
- CLOV Nasdaq
- Market Cap
- BCYC 1.7B
- CLOV 1.8B
- IPO Year
- BCYC 2019
- CLOV N/A
- Fundamental
- Price
- BCYC $13.34
- CLOV $4.08
- Analyst Decision
- BCYC Buy
- CLOV Buy
- Analyst Count
- BCYC 9
- CLOV 2
- Target Price
- BCYC $34.50
- CLOV $5.00
- AVG Volume (30 Days)
- BCYC 417.9K
- CLOV 5.9M
- Earning Date
- BCYC 02-18-2025
- CLOV 03-11-2025
- Dividend Yield
- BCYC N/A
- CLOV N/A
- EPS Growth
- BCYC N/A
- CLOV N/A
- EPS
- BCYC N/A
- CLOV N/A
- Revenue
- BCYC $36,898,000.00
- CLOV $2,115,219,999.00
- Revenue This Year
- BCYC $40.69
- CLOV N/A
- Revenue Next Year
- BCYC N/A
- CLOV $13.05
- P/E Ratio
- BCYC N/A
- CLOV N/A
- Revenue Growth
- BCYC 48.60
- CLOV 13.50
- 52 Week Low
- BCYC $12.17
- CLOV $0.61
- 52 Week High
- BCYC $28.67
- CLOV $4.71
- Technical
- Relative Strength Index (RSI)
- BCYC 34.88
- CLOV 76.81
- Support Level
- BCYC $13.20
- CLOV $3.60
- Resistance Level
- BCYC $15.43
- CLOV $3.94
- Average True Range (ATR)
- BCYC 0.89
- CLOV 0.21
- MACD
- BCYC 0.16
- CLOV 0.09
- Stochastic Oscillator
- BCYC 6.17
- CLOV 95.19
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. Operating in two segments, Insurance and Non-Insurance, Clover Health offers PPO and HMO plans to Medicare Advantage members in multiple states through its Insurance segment. In the Non-Insurance segment, the company participates in the ACO REACH Model. The majority of revenue is generated from the insurance segment, reflecting the significance of its healthcare insurance offerings.